If approved, the nonopioid, centrally acting analgesic would be the first in a new class of medications for fibromyalgia in more than 15 years, Tonix said.
Patients with rheumatoid arthritis and fibromyalgia were at the greatest risk of transitioning to long-term opioid use 1 year after a first prescription, a new study found.
In a study of adults with pain in at least 1 body region, those with fibromyalgia had significantly greater odds of acknowledging pain-related addiction exacerbations.